|
|
|
|
| LEADER |
01424nam a2200301 u 4500 |
| 001 |
EB001897143 |
| 003 |
EBX01000000000000001060148 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
200523 r ||| eng |
| 100 |
1 |
|
|a Chao, Yi-Sheng
|
| 245 |
0 |
0 |
|a Biologics versus immunomodulators for the treatment of ulcerative colitis
|h Elektronische Ressource
|b a review of comparative clinical effectiveness and cost-effectiveness
|c Yi-Sheng Chao, Hannah Loshak
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b CADTH
|c April 17, 2019, 2019
|
| 300 |
|
|
|a 1 PDF file (19 pages)
|b illustration
|
| 653 |
|
|
|a Vaccines / therapeutic use
|
| 653 |
|
|
|a Cost-Benefit Analysis
|
| 653 |
|
|
|a Colitis, Ulcerative / therapy
|
| 653 |
|
|
|a Biological Products / therapeutic use
|
| 653 |
|
|
|a Treatment Outcome
|
| 700 |
1 |
|
|a Loshak, Hannah
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: peer-reviewed summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK549363
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This study aims to review the literature and understand the effectiveness and cost-effectiveness of biologics and immunomodulators among UC patients naïve to both types of drugs
|